Cargando…
A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer
BACKGROUND: We developed and validated a prognostic and predictive computational pathology risk score (CoRiS) using H&E stained tissue images from patients with early-stage non-small cell lung cancer (ES-NSCLC). METHODS: 1330 patients with ES-NSCLC were acquired from 3 independent sources and di...
Autores principales: | Wang, Xiangxue, Bera, Kaustav, Barrera, Cristian, Zhou, Yu, Lu, Cheng, Vaidya, Pranjal, Fu, Pingfu, Yang, Michael, Schmid, Ralph Alexander, Berezowska, Sabina, Choi, Humberto, Velcheti, Vamsidhar, Madabhushi, Anant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282972/ https://www.ncbi.nlm.nih.gov/pubmed/34265509 http://dx.doi.org/10.1016/j.ebiom.2021.103481 |
Ejemplares similares
-
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study
por: Lu, Cheng, et al.
Publicado: (2020) -
Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors
por: Wang, Xiangxue, et al.
Publicado: (2022) -
Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade
por: Vaidya, Pranjal, et al.
Publicado: (2020) -
Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images
por: Wang, Xiangxue, et al.
Publicado: (2017) -
A tumor vasculature–based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitors
por: Alilou, Mehdi, et al.
Publicado: (2022)